This is a phase 1 single-center study to assess the pharmacokinetics (PK), safety and
tolerability of KT07 capsules in healthy adult subjects. This study consists of 2 parts: Part
1 and Part 2.
The primary objectives of Part 1 include selection of suitable PK markers for bioanalysis,
development and validation of GLP bioanalytical methods for follow-up PK studies, assessment
of PK of potential markers following an oral administration of KT07, and provision of PK
sampling strategy for Part 2.
The primary objective of Part 2 is to evaluate the PK profile following a single dose and
multiple doses in healthy adult subjects.